Weber Robert J, Cerchiari Alec E, Delannoy Lucas S, Garbe James C, LaBarge Mark A, Desai Tejal A, Gartner Zev J
Department of Pharmaceutical Chemistry, University of California, San Francisco, 600 16th Street, San Francisco, California 94158, United States.
Chemistry and Chemical Biology Graduate Program, University of California, San Francisco, 600 16th Street, Room 522, San Francisco, California 94158, United States.
ACS Biomater Sci Eng. 2016 Nov 14;2(11):1851-1855. doi: 10.1021/acsbiomaterials.6b00421. Epub 2016 Sep 20.
Purified populations of cells can be reconstituted into organoids that recapitulate aspects of their in vivo structure and function. These organoids are useful as models of healthy and diseased tissue in the basic sciences, in vitro screens, and regenerative medicine. Existing strategies to reconstitute organoids from purified cells face obstacles with respect to cell-viability, multicellular connectivity, scalability, and compatibility with subsequent experimental or analytical techniques. To address these challenges, we developed a strategy for rapidly casting populations of cells into microtissues of prescribed size and shape. This approach begins by chemically remodeling the adhesive properties of living cells with membrane-anchored ssDNA with modest annealing kinetics. Populations of complementary labeled cells are then combined into microwells that rapidly mold the DNA-adhesive cell populations into 3D aggregates of uniform size and shape. Once formed, aggregates are removed from the molds in the presence of "capping" oligonucleotides that block hybridization of residual surface DNA between aggregates in suspension. Finally, transfer of aggregates to biomimetic gels for 3D culture completes the process of reconstitution. This strategy of chemical micromolding allows for control over aggregate internal topology and does not perturb the natural process of self-organization in primary human mammary epithelial cells.
纯化的细胞群体可以重构成类器官,这些类器官能够重现其体内结构和功能的各个方面。这些类器官在基础科学、体外筛选和再生医学中作为健康和患病组织的模型非常有用。现有的从纯化细胞重构类器官的策略在细胞活力、多细胞连接性、可扩展性以及与后续实验或分析技术的兼容性方面面临障碍。为了应对这些挑战,我们开发了一种将细胞群体快速铸造成规定大小和形状的微组织的策略。这种方法首先用具有适度退火动力学的膜锚定单链DNA对活细胞的粘附特性进行化学重塑。然后将互补标记的细胞群体组合到微孔中,这些微孔将DNA粘附细胞群体快速塑造成大小和形状均匀的三维聚集体。一旦形成,聚集体在存在“封端”寡核苷酸的情况下从模具中取出,这些寡核苷酸会阻止悬浮液中聚集体之间残留表面DNA的杂交。最后,将聚集体转移到仿生凝胶中进行三维培养,完成重构过程。这种化学微成型策略能够控制聚集体的内部拓扑结构,并且不会干扰原代人乳腺上皮细胞的自然自组织过程。